This study by Bos and Buis (Annals of Family Medicine, 2017) sought to determine if measuring patients’ blood pressure using a convenient automated office blood pressure monitoring system that registers BP every 5 minutes over 30 minutes (OBP30) could reduce the overtreatment of ‘white-coat hypertension’ (isolated office hypertension).
Prospectively collected data using a cross-sectional study design
201 patients with a mean age of 68.6 years (56.7% female) underwent OBP30 if warranted following an elevated office blood pressure (OBP) in a primary care setting. Indications for the OBP30 included suspected ‘white-coat hypertension’, new diagnosis of hypertension, inconsistent office readings, monitoring of medication effects, suspected therapy resistance and suspected episodes of hypotension. The mean systolic OBP30 was 22.8 mm Hg lower compared to mean systolic OBP (95% CI, 19.8–26.1 mm Hg) and mean diastolic OBP30 was 11.6 mm Hg lower compared to mean diastolic OBP (95% CI, 10.2–13.1 mm Hg). Differences were larger in patients older than 70 years. There was impact on management as the decision to place patients on medications dropped from 79.1% to 24.9% based on OBP30 readings. The authors conclude that OBP30 is an effective technique and “promising method” for reducing overtreatment even in patients not suspected of having ‘white-coat hypertension’ in a primary healthcare setting.
Please log in to access ObGFirst and the 2T US Atlas
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan